ArticleCancers2023

FoxP3 Expression in Tumor-Infiltrating Lymphocytes as Potential Predictor of Response to Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and Non-Small Cell Lung Cancer.

Peter Grell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.